The company's financial foundation is severely impaired, evidenced by a negative equity position of $6.9 million and a critically low current ratio of 0.15 as of 2026Q1.
| Total Current Assets | 1.26M | 1.95M | 955.55K | 62.9M | 605.54K | 178.7K |
| Cash & Short-Term Investments | 313.4K | 706.74K | 157.14K | 2.91M | 128.15K | 774.19K |
| Cash Only | 313.4K | 706.74K | 157.14K | 2.91M | 128.15K | 774.19K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 48.66K | 36.5K | 305.93K | 204.56K | 0 | 0 |
| Days Sales Outstanding | 24.82 | 6.96 | 2.22K | - | - | - |
| Inventory | 734.97K | 963.03K | 108.7K | 0 | 0 | 0 |
| Days Inventory Outstanding | 460.53 | 429.69 | 6.24K | - | - | - |
| Other Current Assets | 0 | 0 | 86.31K | 59.02M | 422.32K | -794.47K |
| Total Non-Current Assets | 379.62K | 416.94K | 518.43K | 1.05M | 1.14M | 1.38M |
| Property, Plant & Equipment | 365.66K | 401.84K | 498.79K | 1.02M | 1.11M | 1.35M |
| Fixed Asset Turnover | 4.30x | 4.76x | 0.10x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 13.96K | 15.09K | 19.64K | 24.19K | 28.7K | 33.22K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 156.69M | 154.45M |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | -156.69M | -154.45M |
| Total Assets | 1.64M | 2.37M | 1.47M | 63.95M | 1.75M | 1.56M |
| Asset Turnover | 0.65x | 0.81x | 0.03x | - | - | - |
| Asset Growth % | 18.79% | 60.59% | -97.7% | 3557.25% | 12.29% | - |
| Total Current Liabilities | 8.35M | 7.92M | 5.88M | 38.5M | 7.3M | 15.8M |
| Accounts Payable | 5.05M | 4.49M | 4.06M | 4.42M | 2.14M | 871.31K |
| Days Payables Outstanding | 2.17K | 2.01K | 233K | 12.92K | 3.22K | - |
| Short-Term Debt | 212.45K | 189.94K | 241.16K | 1.29M | 2.78M | 8.6M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 1.39M | 2.37M |
| Other Current Liabilities | 2.42M | 717.2K | 1.49M | 31.35M | 349.26K | 1.96M |
| Current Ratio | 0.15x | 0.25x | 0.16x | 1.63x | 0.08x | 0.01x |
| Quick Ratio | 0.06x | 0.12x | 0.14x | 1.63x | 0.08x | 0.01x |
| Cash Conversion Cycle | -1.68K | -1.57K | -224.54K | - | - | - |
| Total Non-Current Liabilities | 188.16K | 317.64K | 309.94K | 697.72K | 32.24M | 15.33M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 922 |
| Capital Lease Obligations | 905.46K | 214.75K | 309.94K | 697.72K | 827.73K | 961.91K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 102.9K | 0 | 0 | 31.42M | 14.37M |
| Total Liabilities | 8.54M | 8.23M | 6.19M | 39.2M | 39.54M | 31.13M |
| Total Debt | 400.62K | 499.88K | 638.99K | 2.14M | 3.74M | 9.69M |
| Net Debt | 87.22K | -206.86K | 481.85K | -776.01K | 3.61M | 8.91M |
| Debt / Equity | -0.06x | - | - | 0.09x | - | - |
| Debt / EBITDA | -0.06x | - | - | - | - | - |
| Net Debt / EBITDA | -0.01x | - | - | - | - | - |
| Interest Coverage | -412.40x | -376.13x | -218.27x | -17.22x | -1.41x | -0.13x |
| Total Equity | -6.89M | -5.87M | -4.71M | 24.75M | -37.79M | -29.58M |
| Equity Growth % | -276% | -24.49% | -119.04% | 165.49% | -27.77% | - |
| Book Value per Share | -3.63 | -3.40 | -0.23 | 1.19 | -1.91 | -1.50 |
| Total Shareholders' Equity | -6.89M | -5.87M | -4.71M | 24.75M | -37.79M | -29.58M |
| Common Stock | 247 | 178 | 2.09K | 2.31K | 14.53K | 36.92K |
| Retained Earnings | -77.21M | -75.78M | -68.87M | -58.5M | -42.38M | -32.77M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | -31.42M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Imminent liquidity and insolvency risk
As reported in recent quarterly filings, XAGE's total assets have plummeted from $63.9 million in 2023Q4 to just $1.6 million by 2026Q1, signaling a severe contraction in the company's resource base that reflects an unsustainable burn rate and a lack of meaningful capital replenishment.
The dramatic decline in asset value suggests that the company has been forced to liquidate or consume its core resources to fund ongoing operations. This trajectory indicates that the business model has failed to achieve the scale necessary to preserve its balance sheet integrity, leaving the firm in a precarious position.
Based on the 2026Q1 financial statements, XAGE holds only $313,400 in cash against a current ratio of 0.15, which indicates that the company lacks the necessary liquidity to meet its short-term obligations without immediate and potentially highly dilutive external financing or a strategic capital injection.
A current ratio of 0.15 is exceptionally low and suggests that current liabilities vastly exceed the company's ability to generate near-term cash. Investors should monitor this closely, as the current cash position appears insufficient to support even a single quarter of the company's historical operating expenditure levels.
According to the latest balance sheet data, XAGE has fallen into a negative equity position of -$6.9 million as of 2026Q1, a trend driven by the accumulation of -$77.2 million in retained earnings that highlights the persistent failure to generate profitable returns on invested capital.
The shift into negative equity territory suggests that the company has effectively exhausted its original shareholder capital. This condition often complicates future financing efforts and may indicate that the firm's liabilities are now significantly greater than the fair market value of its underlying assets.
As indicated by the provided financial data, the company's asset base is heavily skewed toward minimal PPE and negligible goodwill, with total assets of $1.6 million in 2026Q1 providing little tangible collateral to support the company's outstanding debt obligations or future operational requirements.
The lack of substantial tangible assets implies that the company's value is almost entirely tied to speculative intangible potential rather than physical infrastructure. This composition makes the balance sheet highly sensitive to any impairment of its intellectual property or failure to secure regulatory milestones for its pipeline.
Quick answers to the most common questions about buying XAGE stock.
As of 2025, Longevity Health Holdings Inc. (XAGE) had total assets of $2.4M including $2.0M in current assets.
Longevity Health Holdings Inc. (XAGE) carries total debt of $0.5M, offset by $0.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Longevity Health Holdings Inc. (XAGE) has total shareholders' equity (book value) of $-5.9M ($-3.40 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Longevity Health Holdings Inc. (XAGE) reported a current ratio of 0.25x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.